Fasano M B, Wood R A, Cooke S K, Sampson H A
Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.
J Pediatr. 1992 Jun;120(6):878-81. doi: 10.1016/s0022-3476(05)81953-5.
We evaluated the safety of the measles-mumps-rubella (MMR) combination vaccine in 140 children with egg hypersensitivity. All children, regardless of vaccine skin test results or severity of egg hypersensitivity, were safely immunized with the MMR vaccine. Systemic reactions to MMR vaccine in two nonallergic children were documented, indicating that reactions unrelated to egg protein can occur. With the use of a competitive enzyme-linked immunosorbent assay, the standard MMR injection was found to contain approximately 37 pg of ovalbumin-like material. This study provides 95% confidence that at least 97.5% of egg-allergic children will tolerate MMR vaccine without significant difficulty. Skin testing was not found to be helpful in predicting an adverse reaction. We recommend that the American Academy of Pediatrics consider revising its current policy regarding skin test response to MMR vaccine and administration of MMR vaccine to egg-allergic children.
我们评估了麻疹-腮腺炎-风疹(MMR)联合疫苗在140名鸡蛋过敏儿童中的安全性。所有儿童,无论疫苗皮肤试验结果或鸡蛋过敏的严重程度如何,均通过MMR疫苗安全接种。记录了两名非过敏儿童对MMR疫苗的全身反应,表明可能发生与鸡蛋蛋白无关的反应。通过竞争性酶联免疫吸附测定法,发现标准MMR注射剂含有约37 pg的卵清蛋白样物质。这项研究提供了95%的置信度,即至少97.5%的鸡蛋过敏儿童能够耐受MMR疫苗而不会有显著困难。未发现皮肤试验有助于预测不良反应。我们建议美国儿科学会考虑修订其目前关于对MMR疫苗皮肤试验反应及给鸡蛋过敏儿童接种MMR疫苗的政策。